The Vigilint Advantage: Patient to Doctor in 30 seconds
May 14, 2020: In an interview with The Washington Post FedEx CEO Frederick W. Smith credits the company's long-term medical advisory company, VIGILINT, for early COVID-19 containment strategies. Dr. Eric Ossmann advised FedEx immediately upon discovery of the virus in Wuhan, China in January 2020.
Intelligence-driven, global protection
Interactive Worldwide Health Risk Map - Updated on an Ongoing Basis
On March 31, 2020, the U.S State Department issued a Global Level 4 Health Advisory - DO NOT TRAVEL. All US citizens should avoid international travel due to the global impact of COVID-19.
Countries experiencing a significant strain in their public healthcare systems due to COVID-19 cases, and countries with additional travel advisories unrelated to COVID-19 from the US State Department and the CDC, have been identified in the map below.
hover over any country for THE LATEST TRAVEL ADVISORIES, INFECTIOUS DISEASE WARNINGS, and proprietary healthcare infrastructure intel.
Nestled amid a global pandemic, athletes from 206 countries are making their way to Japan to compete in the 2020 Tokyo Olympic Games. Not the first Games to be affected by widespread health concerns: although the novel Zika virus was a concern during the 2016 Rio Olympics, the World Health Organization (WHO) announced at… Read more about Spectators barred from the Olympics due to COVID-19 risk
For nearly a year, schools in the United States have adapted to the pandemic by utilizing distance-learning models with varying success levels. Many studies indicate that the interruption to in-person learning has drastically affected standardized test scores, graduation rates, absenteeism, and social development for all students. The heaviest toll falls on Black, Hispanic, and low-income… Read more about Reopening the Schools – Weighing the Risks
In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Read more about COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines
On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT looks back at the critical events that… Read more about COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis
There is some risk of COVID-19 transmission from surfaces, but the primary disease transfer mode is airborne transmission. Several studies have analyzed the detection of COVID-19 on various surfaces. One such study, published by the New England Journal of Medicine in March 2020, largely shaped the discussion around SARS-COV-2 (the virus causing COVID-19 disease) transmissions… Read more about COVID-19 Transmission: Surfaces
The Trump administration is reversing its COVID-19 vaccination strategy by authorizing the release of Pfizer-BioNtech and Moderna’s federally stockpiled vaccines. The previous policy withheld half the purchased doses to ensure the supply necessary for second doses, and states could only receive vaccines based on their adult population size. The new distribution strategy unveiled yesterday is intended… Read more about COVID-19 Update: Vaccine Distribution
Real Physicians. Real Experience. Real-time Support.
During a recent trip to Hanoi, Vietnam, Tara's minor strep throat progressed to a severe one-in-a-million case and almost cost her her life. Tara and her travel companion discuss the terrifying ordeal and how VIGILINT and Cleveland Clinic's GMAP program saved her life.
Sign up for our Monthly Newsletter
Featuring global health news from our Medical Intelligence Center